During the invalidation, CNIPA rejected all claims for lack of inventive step in view of liraglutide, a molecule with a similar structure and mechanism of action. Novo Nordisk responded by arguing ...

In drug discovery, targeted protein degradation is a method that selectively eliminates disease-causing proteins. A University of California, Riverside team of scientists has used a novel approach to ...

BGI Genomics and partners have published a transformative study in Nature Communications that links genetic differences in ...

Big Pharma is sticking to the recent molecular glue investment trend, with Pfizer now the latest major drugmaker to get in on the action. Pfizer is laying out $49 million upfront in a partnership ...

But no one knew whether they might work as a team to enter an egg, or how. In the new study, Andrea Pauli, a molecular and developmental biologist at the Research Institute of Molecular Pathology ...

We used a two-step extraction process to isolate as diverse chemical mixtures as possible," says Georg Braun, postdoctoral researcher in Beate Escher's working group and first author of the study.